We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
-4.34%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$63.9M
Cap. Flow
-$54.5M
Cap. Flow %
-18.25%
Top 10 Hldgs %
28.29%
Holding
166
New
33
Increased
12
Reduced
17
Closed
48

Top Buys

Rank Stock Value
1
PEPLU
PepperLime Health Acquisition Corporation Unit
PEPLU
+$7.47M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$5.84M
3
DXCM icon
DexCom
DXCM
+$5.47M
4
KPTI icon
Karyopharm Therapeutics
KPTI
+$5.36M
5
IMGN
Immunogen Inc
IMGN
+$5.09M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$8.71M
2
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$7.2M
3
IMTX icon
Immatics
IMTX
+$6.32M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$6.19M
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$5.62M

Sector Composition

Rank Sector Weight
1 Healthcare 78.49%
2 Financials 7.32%
3 Industrials 1.2%
4 Technology 0.83%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVRD
51
Tvardi Therapeutics
TVRD
$23.4M
$2M 0.67%
+4,583
New +$1.88M
TGVCU
52
DELISTED
TG Venture Acquisition Corp. Units
TGVCU
$2M 0.67%
200,000
– –
GIW
53
DELISTED
GigInternational1, Inc. Common Stock
GIW
$2M 0.67%
200,000
– –
MOBX icon
54
Mobix Labs
MOBX
$26M
$1.98M 0.66%
20,000
– –
LAAA
55
DELISTED
Lakeshore Acquisition I Corp. Ordinary Shares
LAAA
$1.98M 0.66%
200,000
– –
JYAC
56
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$1.97M 0.66%
200,000
– –
TSVT
57
DELISTED
2seventy bio
TSVT
$1.96M 0.66%
+115,000
New +$1.95M
ALT icon
58
Altimmune
ALT
$599M
$1.96M 0.66%
+322,000
New +$2.37M
AGIO icon
59
Agios Pharmaceuticals
AGIO
$1.93B
$1.93M 0.64%
+66,196
New +$2.02M
GBT
60
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.87M 0.63%
54,000
– –
PRDS
61
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.83M 0.61%
253,000
+53,000
+27% +$521K
CTMX icon
62
CytomX Therapeutics
CTMX
$754M
$1.77M 0.59%
663,800
– –
RCOR
63
DELISTED
Renovacor, Inc.
RCOR
$1.65M 0.55%
388,845
– –
PRCT icon
64
Procept Biorobotics
PRCT
$1.17B
$1.65M 0.55%
+47,077
New +$1.13M
DHACU
65
DELISTED
Digital Health Acquisition Corp. Unit
DHACU
$1.51M 0.51%
150,000
– –
ADRT
66
DELISTED
Ault Disruptive Technologies Corporation
ADRT
$1.5M 0.5%
+150,000
New +$1.49M
SLGC
67
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.44M 0.48%
+180,000
New +$1.59M
CTIC
68
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$1.4M 0.47%
299,800
-1,885,200
-86% -$5.62M
ITCI
69
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.38M 0.46%
+22,500
New +$1.17M
CRIS icon
70
Curis
CRIS
$7.83M
$1.29M 0.43%
1,352
-721
-35% -$920K
BURU
71
DELISTED
NUBURU INC
BURU
$1.27M 0.43%
643
– –
PROF
72
Profound Medical
PROF
$269M
$1.13M 0.38%
124,945
-175,055
-58% -$1.69M
CUTR
73
DELISTED
Cutera, Inc.
CUTR
$1.03M 0.35%
+15,000
New +$607K
FATBW
74
DELISTED
FAT Brands Inc. Warrant
FATBW
$1.02M 0.34%
227,000
– –
MURFU
75
DELISTED
Murphy Canyon Acquisition Corp. Unit
MURFU
$1.01M 0.34%
+100,000
New +$1.01M
1 2
3
4 5

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Altium Capital Management held 166 positions worth $299M, down 18% from $363M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Altium Capital Management withdrew a net $54.5M in Q1 2022, closing 48 positions and reducing 17 holdings. Its most notable exit was PepperLime Health Acquisition Corporation Class A Ordinary Share, an estimated $7.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 80% a quarter earlier, followed by Financials and Industrials.

Against the trend, Altium Capital Management opened a new position in PepperLime Health Acquisition Corporation Unit worth $7.23M.

  • Altium Capital Management's largest Q1 2022 buy was PepperLime Health Acquisition Corporation Unit: 735,000 shares worth $7.23M.
  • Altium Capital Management added most to NEVRO CORP. in Q1 2022, an estimated $2.52M increase.
  • Altium Capital Management's biggest Q1 2022 reduction was Lantheus, cutting an estimated $8.71M.
  • Altium Capital Management fully exited PepperLime Health Acquisition Corporation Class A Ordinary Share in Q1 2022, selling an estimated $7.2M.
  • Altium Capital Management's ten largest holdings make up 28% of its $299M portfolio in Q1 2022.
  • Altium Capital Management opened 33 new positions and closed 48 in Q1 2022.
  • Altium Capital Management's portfolio value fell 18% quarter-over-quarter to $299M.

Based on Altium Capital Management's 13F filing for Q1 2022, filed 16 May 2022.